Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Undisclosed
Therapeutic Area : Technology
Highest Development Status : Discovery
Partner/Sponsor/Collaborator : Jiangsu Hengrui Medicine
Deal Size : Undisclosed
Deal Type : Collaboration
Medicilon & Hengrui Pharma Deepen Collaboration on ADCs, Small Nucleic Acids, & CGT Drugs
Details : Medicilon & Hengrui will collaborate to focus on the preclinical evaluation of new drug modalities such as ADCs, small molecules, etc & to advance the innovation to compete on an international level.
Product Name : Undisclosed
Product Type : Small molecule
Upfront Cash : Undisclosed
July 31, 2024
Lead Product(s) : Undisclosed
Therapeutic Area : Technology
Highest Development Status : Discovery
Partner/Sponsor/Collaborator : Jiangsu Hengrui Medicine
Deal Size : Undisclosed
Deal Type : Collaboration
LOOKING FOR A SUPPLIER?